Clinicopathological Features Related to the Efficacy of CDK4/6 Inhibitor-Based Treatments in Metastatic Breast Cancer

BACKGROUND: Resistance to endocrine therapy has been a major obstacle in the management of hormone receptor (HR)-positive metastatic breast cancer (MBC). Meanwhile, a number of treatments are available to such patients, and physicians often encounter difficulties in choosing the most appropriate tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Shikanai, Ayana, Horimoto, Yoshiya, Ishizuka, Yumiko, Uomori, Toshitaka, Nakai, Katsuya, Arakawa, Atsushi, Saito, Mitsue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738870/
https://www.ncbi.nlm.nih.gov/pubmed/35002243
http://dx.doi.org/10.1177/11782234211065148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738870/
https://www.ncbi.nlm.nih.gov/pubmed/35002243
http://dx.doi.org/10.1177/11782234211065148

Ejemplares similares